BSX Dividend: Boston Scientific Corp Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	19,350	16,747	14,240	12,682	11,888	9,913
Revenue Growth (YoY)	22%	18%	12%	7%	20%	-8%
Cost of Revenue	6,082	5,238	4,322	3,932	3,681	3,446
Gross Profit	13,268	11,509	9,918	8,750	8,207	6,467
Selling, General & Admin	6,666	5,984	5,190	4,520	4,287	3,736
Research & Development	1,942	1,615	1,414	1,323	1,204	1,139
Operating Expenses	9,514	8,452	7,490	6,679	6,095	5,565
Other Non Operating Income (Expenses)	242	-28	-15	-16	-9	8
Pretax Income	3,270	2,282	1,985	1,141	1,076	-79
Income Tax Expense	485	436	393	443	36	2
Net Income	2,791	1,853	1,570	642	985	-115
Net Income Growth	56%	18%	145%	-35%	-957%	-102%
Shares Outstanding (Diluted)	1,495.5	1,485.9	1,463.5	1,439.7	1,433.8	1,416.7
Shares Change (YoY)	1%	2%	2%	0%	1%	0%
EPS (Diluted)	1.86	1.25	1.07	0.45	0.69	-0.08
EPS Growth	54%	17%	138%	-35%	-963%	-102%
Free Cash Flow	3,823	2,644	1,792	938	1,317	986
Free Cash Flow Per Share	2.55	1.77	1.22	0.65	0.91	0.69
Gross Margin	68.56%	68.72%	69.64%	68.99%	69.03%	65.23%
Operating Margin	19.4%	18.25%	17.05%	16.33%	17.76%	9.09%
Profit Margin	14.42%	11.06%	11.02%	5.06%	8.28%	-1.16%
Free Cash Flow Margin	19.75%	15.78%	12.58%	7.39%	11.07%	9.94%
EBITDA	5,105	3,913	3,256	2,874	2,853	1,691
EBITDA Margin	26.38%	23.36%	22.86%	22.66%	23.99%	17.05%
D&A For EBITDA	1,351	856	828	803	741	789
EBIT	3,754	3,057	2,428	2,071	2,112	902
EBIT Margin	19.4%	18.25%	17.05%	16.33%	17.76%	9.09%
Effective Tax Rate	14.83%	19.1%	19.79%	38.82%	3.34%	-2.53%

Boston Scientific Corp (BSX) Price